Opinion favours pharma brand owners over importers’ product repackaging
The rights of brand owners to prevent parallel importers from repackaging products bearing their trade marks beyond what is necessary have been reinforced in a new opinion issued by a legal adviser to the EU’s highest court, an expert in brand protection has said.